Media Coverage · May 20, 2014

Acticor Biotech starts a crowdfunding campaign

logo-anaxago-e1422010654724 (1)

Acticor Biotech, a new biotechnology company entirely dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes is opening its capital to crowdfunding.

More details about the company.

Read next in 'Media Coverage'